Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...
The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...
Singapore Business Review on MSN1d
GIC, Temasek to acquire ‘significant stake’ in biotech CRO NovotechNovotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...
SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...
Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...
Temasek and GIC will acquire a significant stake in Novotech, whose ebitda has grown fivefold since TPG’s initial investment ...
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of small ...
SYDNEY, March 31, 2025--(BUSINESS WIRE)--Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback